Institutional investors purchased a net $1.0 million shares of INO during the quarter ended June 2016, and now own 29.01% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO CAPITAL MARKETS (CANADA) Bought 5.0 Thousand shares of Inovio Pharmaceuticals In...